Skip to content

Clinical trials

Phase 1/2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 1/2 Clear all

248 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20014
20024
20039
20045
200511
200616
20078
20088
20099
20108
20114
20128
201313
20146
20157
201614
201712
201811
20199
20206
202111
202211
20239
202413
20258
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed105
Terminated41
Recruiting39
Active, not recruiting25
Unknown status25
Withdrawn11
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center19
M.D. Anderson Cancer Center16
National Cancer Institute (NCI)10
Novartis Pharmaceuticals7
Masonic Cancer Center, University of Minnesota5
Princess Maxima Center for Pediatric Oncology5
Bellicum Pharmaceuticals4
City of Hope Medical Center4
Memorial Sloan Kettering Cancer Center4
Northwestern University4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma248
Leukemia, Myeloid, Acute110
Leukemia79
Lymphoma, Non-Hodgkin74
Myelodysplastic Syndromes64
Leukemia, Lymphocytic, Chronic, B-Cell56
Burkitt Lymphoma54
Lymphoma, Large B-Cell, Diffuse50
Lymphoma, Mantle-Cell48
Lymphoma46

Trials

Showing 1 to 25 of 248. Each trial links to its page on Pharma Observatory.

148 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.